TrialPloS one2018

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305.

Shashi N Kapadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.